Objective: To test medication adherence using the Compliance-Questionnaire-Rheumatology (CQR).
Methods: Invitation letter and CQR were sent to 240 patients with rheumatoid arthritis. Followup CQR was sent 3 months later. Adherence was evaluated using CQR 80% cutoff scores.
Results: Seventy-eight patients who were being treated with disease-modifying antirheumatic drugs provided full information on the CQR at both points in time. Eleven patients (14.1%) were classified as adherent based on taking compliance (TC), with only 3 patients (3.8%) adherent in regard to correct dosing (CD) [followup: 13 (16.7%) and 3 (3.8%) for TC and CD, respectively]. Nonadherence was not related to disease activity or side effects.
Conclusion: We demonstrated low adherence, suggesting differences between doctors' records and patients' practice of antirheumatic drug therapy.
Keywords: ADHERENCE; COMPLIANCE; CQR; DISEASE-MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID ARTHRITIS.